In response to adverse environmental conditions many organisms from nematodes to mammals deploy a dormancy strategy, causing states of developmental or reproductive arrest that enhance somatic maintenance and survival ability at the expense of growth or reproduction. Dormancy regulation has been studied in C. elegans and in several insects, but how neurosensory mechanisms act to relay environmental cues to the endocrine system in order to induce dormancy remains unclear. Here we examine this fundamental question by genetically manipulating aminergic neurotransmitter signaling in Drosophila melanogaster. We find that both serotonin and dopamine enhance adult ovarian dormancy, while the downregulation of their respective signaling pathways in endocrine cells or tissues (insulin producing cells, fat body, corpus allatum) reduces dormancy. In contrast, octopamine signaling antagonizes dormancy. Our findings enhance our understanding of the ability of organisms to cope with unfavorable environments and illuminate some of the relevant signaling pathways.
In response to adverse environmental conditions many organisms from nematodes to mammals deploy a dormancy strategy, causing states of developmental or reproductive arrest that enhance somatic maintenance and survival ability at the expense of growth or reproduction. Dormancy regulation has been studied in C. elegans and in several insects, but how neurosensory mechanisms act to relay environmental cues to the endocrine system in order to induce dormancy remains unclear. Here we examine this fundamental question by genetically manipulating aminergic neurotransmitter signaling in Drosophila melanogaster. We find that both serotonin and dopamine enhance adult ovarian dormancy, while the downregulation of their respective signaling pathways in endocrine cells or tissues (insulin producing cells, fat body, corpus allatum) reduces dormancy. In contrast, octopamine signaling antagonizes dormancy. Our findings enhance our understanding of the ability of organisms to cope with unfavorable environments and illuminate some of the relevant signaling pathways.
Dormancy is a widespread phenotypically plastic response that enables organisms -both vertebrates and invertebrates -to survive adverse environmental conditions [1] [2] [3] . Two types of dormancy can be distinguished. Quiescence is a direct, immediate response to unfavorable conditions; it may be facultative or inevitable and can be adaptive or not. In contrast, diapause represents an adaptive response to anticipatory token cues (e.g., temperature, photoperiod) in unfavorable, predictable environments and includes defined physiological phases (prediapause, diapause, postdiapause). Both responses profoundly alter metabolism, increase stress tolerance, and promote survival ability, and have been studied in the nematode C. elegans as well as in various insects [4] [5] [6] [7] [8] [9] . Several endocrine signaling pathways have been implicated in inhibiting dormancy under normal conditions, but little is known about the mechanisms that lead to the induction of dormancy by suppressing these pathways 1, 2, 10 .
In fruit flies (Drosophila) and other insects, adult females enter ovarian dormancy by arresting gonadal maturation in response to cold (<13 °C; enhanced by shorter photoperiods), a state that is accompanied by markedly improved stress resistance, slowed aging and increased adult survival 5, 9, [11] [12] [13] [14] [15] [16] . This response involves the downregulation of several gonadotropic hormones, including juvenile hormone (JH, produced in the corpus allatum [CA] gland), 20-hydroxy-ecdysone (20E; produced in the ovary), and insulin-like peptides (ILPs = dILPs in Drosophila; produced in insulin-producing cells [IPCs] in the brain) 1, 5, 9, 15, 17 . For instance, dormant fruit flies, monarch butterflies and mosquitos exhibit reduced JH and/or 20E levels [18] [19] [20] [21] , and dormancy can be terminated by topical application of JH or 20E 11, 12, 19, [21] [22] [23] . Similarly, surgical or genetic ablation of the CA in grasshoppers, butterflies and fruit flies 4, 24, 25 and genetic downregulation of components of insulin/insulin-like signaling (IIS) in Drosophila 12, 26 faithfully phenocopy major aspects of dormancy, including halted or decreased reproduction, improved stress resistance and greatly extended lifespan.
In support of a direct role of the IIS pathway in regulating dormancy in Drosophila, we have recently shown that two insulin-like peptides, dILP2 and dILP5, produced in the IPCs, act as major endocrine antagonists of dormancy 15 (also see 14 ) . Since the IPCs adjust insulin release in response to environmental inputs (e.g., cold, nutrients) [27] [28] [29] , and because IIS is required for the production of both JH and 20E 12, [30] [31] [32] , these cells likely represent a critical target of dormancy-inducing cues. Yet, how neurosensory signals relay dormancy-inducing cues to the IPCs and to peripheral tissues (e.g., CA, fat body, ovary) in order to control dormancy is poorly understood; neurotransmitter signaling might represent an attractive candidate mechanism in this context.
Indeed, previous data suggest that aminergic neurotransmitters, such as the biogenic amines serotonin, dopamine or octopamine, might be involved in regulating dormancy, yet the evidence to date is largely correlational 10, [33] [34] [35] [36] . For example, these neurotransmitters regulate many processes that are also known to be affected by
Results
Serotonin promotes dormancy by regulating insulin signaling. Insulin/insulin-like growth factor signaling (IIS) is thought to play a major role in dormancy regulation but whether neurotransmitters can modulate this control is largely unclear. Since dILPs act as dormancy antagonists 14, 15 , and because the production of dILPs by the IPCs is inhibited by the serotonin receptor 48, 49 , we first asked whether manipulating serotonin receptor levels in the IPCs affects dormancy.
To address this question, we downregulated the 5-HT1A serotonin receptor in the IPCs using RNAi under the control of two different IPC-specific GAL4 drivers (dilp2(p)-Gal4 58, 59 ; dilp2-Gal4 [60] [61] [62] ). Knockdown of the 5-HT1A receptor in the IPCs strongly suppressed the dormancy response ( Fig. 1A and Supplementary Figure S1A ), thus lending support to the notion that elevated IIS acts to inhibit dormancy 15 .
To determine whether upregulation of serotonin signaling would have the opposite effect, we constitutively activated serotonergic neurons by overexpressing a low-threshold, voltage-gated bacterium sodium channel NaChBac under the control of a tryptophan hydroxylase (TRH)-GAL4 line which drives expression in 5HT-positive neurons (TRH-GAL4 > UAS-NaChBac 63, 64 ). The resulting hyperexcitation of serotonergic neurons significantly increased the proportion of females in reproductive dormancy ( Fig. 1B) , thus confirming that serotonin represents a positive regulator of dormancy, presumably by reducing IIS.
To examine whether serotonin signaling might regulate dormancy by modulating IIS, we measured dILP mRNA levels upon manipulation of the serotonin receptor in the IPCs. In agreement with previous data showing that the 5-HT1A serotonin receptor inhibits dILP production under normal (non-dormancy) conditions 49 , we found that under dormancy conditions RNAi against the 5-HT1A receptor in the IPCs causes a derepression (upregulation) of dilp2 and dilp5 but not of dilp3 ( Fig. 1C -E).
To further corroborate that serotonin signaling affects dormancy via IIS we assayed the expression levels of a major transcriptional target of the IIS/TOR (Target Of Rapamycin) pathway, the translation inhibitor 4E-BP, outside the brain. Reduced activity of the IIS/TOR pathway results in nuclear translocation of the forkhead box O transcription factor FOXO, whose activation in turn induces 4E-BP 65 . In line with the observed upregulation of dilp2 and dilp5, we found that knockdown of the 5-HT1A receptor in the IPCs reduces expression of 4E-BP throughout the body (thorax and abdomen) ( Fig. 1F ), in agreement with reduced systemic IIS. These results indicate that dormancy is under serotonergic control via the inhibition of dILP production and release by the serotonin receptor, leading to reduced IIS and promoting entry into the dormant state.
Octopamine inhibits dormancy but GABA has no effect. We next investigated whether also octopaminergic and GABAergic signaling might contribute to the regulation of dormancy induction. Both octopaminergic and GABAergic signaling are known to influence the production and/or release of hormones involved in dormancy regulation, i.e. dILPs 29, [49] [50] [51] 66 as well as ecdysone 52, 53, 67 , so these neurotransmitters might affect dormancy via modulating these hormones.
Silencing of the octopamine receptor in mushroom bodies (OAMB) in the IPCs had no effect on dormancy levels ( Fig. 1G and Supplementary Figure S1B ), yet activation of octopaminergic neurons with a tyrosine decarboxylase 2 (TDC2)-GAL4 driver (TDC2-GAL4 > UAS-NaChBac) decreased dormancy levels ( Fig. 1H ). Thus, while OAMB RNAi did not affect dormancy, the fact that increased octopaminergic signaling reduces dormancy suggests that octopamine likely represents an antagonist that is downregulated under conditions of dormancy.
In contrast to octopamine signaling, GABAergic signaling did not consistently affect dormancy. Although downregulation of the metabotropic GABA(B) receptor (GBR) in the IPCs using the dilp2(p)-GAL4 driver decreased dormancy levels (see Supplementary Figure S1C ), we could not corroborate this result with a second, independent dilp2-GAL4 driver (Fig. 1I ). Consistent with the ineffectiveness of GABA in modulating dormancy, constitutive activation of GABAergic neurons with a glutamic acid decarboxylase (GAD1)-GAL4 driver (GAD1-GAL4 > UAS-NaChBac) also had no effect on dormancy ( Fig. 1J ). To further corroborate these negative results we manipulated the leptin-like cytokine Unpaired2 (Upd2), a fat body-secreted factor known to block the GABA-mediated inhibition of dILP release from the IPCs and to enhance systemic IIS 29 Figure S1A ), suggesting that serotonin promotes dormancy. (B) Constitutive activation of serotoninergic neurons for 11 days at 12 °C and 16 h:8 h L:D increases ovarian dormancy, confirming that serotonin is a positive regulator of dormancy. Figure 1A Figure S1B ). (H) In contrast, however, constitutive activation of octopaminergic neurons decreases dormancy levels. (I) Knockdown of GBR in the IPCs with dilp2-GAL4 has no effect on dormancy (but see Supplementary Figure S1C for a positive yet inconsistent result with dilp2(p)-GAL4). (J) In support of the notion that GABA does not affect dormancy, constitutive activation of GABAergic neurons is ineffective in regulating dormancy. (K) Overexpression of Upd2 in fat body with cg-GAL4, a manipulation that blocks GABA-mediated inhibition of dILP release from the IPCs, does not affect dormancy (also see Supplementary Figure S1D ). Shown are the percentage of females in dormancy (mean ± binomial SE); assays were performed with 5-10 replicates per genotype, each replicate consisting of ~50 females. ***p < 0.001. 68 and pumpless (ppl)-GAL4 69, 70 , the percentage of flies in dormancy was unaffected ( Fig. 1K and Supplementary Figure S1D ). Dormancy entry might thus be regulated by octopaminergic signaling butinterestingly -not by GABAergic signaling, even though GABA is known to impact IIS.
Dopamine is a positive regulator of dormancy. In some dormant/diapausing insects the levels of dopamine are elevated, suggesting that dopamine signaling might promote dormancy, yet direct evidence for this regulation is lacking [33] [34] [35] [36] . To determine whether -as predicted -dopamine levels are indeed elevated in dormant D. melanogaster females we used high performance liquid chromatography (HPLC). Control female flies maintained under dormancy conditions (11 days at 12 °C; with a light [L]:dark [D] cycle of either 8 h:16 h or 12 h:12 h) showed a more than two-fold increase of dopamine titers (2.07 ± 0.32 and 2.49 ± 0.28 µg dopamine/g, respectively) as compared to non-dormant controls raised at 23 °C under long day conditions (0.90 ± 0.07 µg dopamine/g fly) ( Fig. 2A ), thereby confirming that reduced dopamine is a robust read-out of dormancy state.
To directly test the role of dopamine in dormancy we examined mutant alleles at two loci required for dopamine synthesis: a loss-of-function mutant of pale (ple), encoding tyrosine-hydroxylase (ple 4 /+; see Supplementary  Table S1 [71] [72] [73] , and a hypomorphic mutant of Ddc, encoding DOPA-decarboxylase (Ddc hyp74,75 ). Both mutants exhibited a markedly reduced dormancy response under dormancy-inducing conditions (Fig. 2B) , with well advanced ovarian development, as compared to controls (Fig. 2C) . Similarly, a hypomorphic mutant of the Dopamine Receptor 1 (DopR1 hyp75,76 ) showed a significantly reduced dormancy response ( Fig. 2B) , accompanied by enhanced ovarian development (data not shown).
Since dopamine deficiency decreased dormancy levels in our experiments, we predicted that increased dopamine should promote dormancy entry, as might be expected based on correlational observations in other insect species [33] [34] [35] [36] . Indeed, female mutants of ebony (e 1 ), which are characterized by a two-fold increase in dopamine relative to wildtype 77, 78 , showed strongly increased dormancy levels, with associated ovarian arrest ( Fig. 2B,C) . Similarly, dormancy levels were elevated when constitutively activating dopaminergic neurons with a tyrosine hydroxylase (TH) -GAL4 driver (TH-GAL4 > UAS-NaChBac) ( Fig. 2D ). These results thus provide direct evidence that dopamine represents a positive regulator of dormancy state.
Dopamine promotes dormancy via DopR1 in IPCs, CA and fat body. Previous data suggest that
IIS can interact with dopamine signaling and metabolism [79] [80] [81] [82] , and two dopamine receptors (DopR1; dopamine 2-like receptor = D2R) are expressed in the CA (the gland producing JH) and fat body (the insect equivalent of mammalian adipose and liver) 57 , two endocrine tissues that are critically important for the physiological regulation of dormancy/diapause in insects 7, 8, 18, 19, 24, 83 . However, direct evidence for an involvement of dopamine in dormancy control is lacking; we thus aimed to downregulate dopamine receptor signaling at these endocrine sites.
Silencing the DopR1 receptor in the IPCs markedly decreased dormancy levels ( Fig. 3A and Supplementary Figure S2A ). Dormancy levels were also strongly reduced when silencing DopR1 in the CA using two independent CA-specific GAL4 drivers, Aug21-GAL4 84 and hmgcr Di-11 -GAL4 85 ( Fig. 3B and Supplementary Figure S2B ). In contrast, RNAi directed against D2R in the CA had no effect on dormancy levels ( Fig. 3B and Supplementary Figure S2B ). We obtained equivalent results when we silenced both receptors in the fat body via cg-GAL4 or with ppl-GAL4: RNAi silencing of DopR1 decreased dormancy, while D2R-RNAi was completely ineffective ( Fig. 3C and Supplementary Figure S2C ). These observations suggest that signaling via DopR1 -but not via D2R -in the IPCs, CA and fat body contributes to the regulation of dormancy.
PKA is required in IPCs, CA and fat body for dormancy induction. To further investigate the dopaminergic control of dormancy we manipulated protein kinase A (PKA) signaling: since both DopR1 and D2R converge on PKA 86, 87 , dopamine might affect dormancy via PKA signaling. To test this notion, we impaired PKA activity in IPCs, CA and fat body by overexpressing mutated forms of the regulatory subunits of PKA (PKA-R), thereby inhibiting PKA signaling (UAS-PKA-R33; UAS-PKA-R35). Constitutive inhibition of PKA in the IPCs significantly decreased dormancy levels ( Fig. 3D and Supplementary Figure S2D ). Likewise, impairing PKA signaling in the CA completely suppressed the dormancy response ( Fig. 3E and Supplementary Figure S2E) , with females showing advanced vitellogenic stages (Fig. 3G ). When expressing both PKA-R transgenes in fat body with cg-GAL4 or ppl-GAL4 we similarly observed strongly reduced dormancy ( Fig. 3F and Supplementary Figure S2F ). These data indicate that PKA signaling is required in the IPCs, CA and fat body for the proper induction of dormancy.
Finally, given that IIS acts in the CA to control JH production 85, 88 , and since IIS and JH might be involved in a positive feedback loop 89 , we were interested in measuring transcriptional readouts of IIS and JH signaling in whole bodies from flies expressing PKA-R in the CA under dormancy conditions. High IIS and JH signaling are expected to inhibit dormancy entry (see Introduction). Consistent with increased IIS upon impaired PKA signaling, the levels of 4E-BP (which is normally inhibited by IIS 65 ) were decreased. Since IIS is required for the production of JH, a hormone that inhibits dormancy, we also investigated two transcriptional readouts of JH signaling 25 . Impaired PKA activity caused upregulation of Jon25Bii, normally induced by JH, and downregulation of obp99b, typically downregulated by JH ( Fig. 4A-F) , consistent with high JH signaling activity. PKA signaling thus likely affects dormancy via IIS and JH, consistent with the notion that dormancy entry requires the downregulation of both IIS and JH signaling.
Discussion
Dormancy (i.e., diapause or quiescence) is a physiological state of improved stress resistance and survival ability in response to harsh environmental conditions. Although many physiological studies have examined the hormonal control of this life-history strategy, the identity and effects of neurosensory signals acting upstream of the endocrine system to regulate dormancy are poorly understood. Here we have used neurogenetic manipulations SCIEnTIFIC REPORTS | (2018) 8:2030 | DOI:10.1038/s41598-018-20407-z to directly investigate how neurotransmitters regulate dormancy in Drosophila melanogaster. Our results show that by acting in endocrine cells and tissues and by modulating hormonal signaling, serotonin and dopamine positively regulate while octopamine counteracts dormancy (Fig. 5 ) suggesting that these neurotransmitters play opposing roles.
Although serotonin has previously been implicated in dormancy/diapause regulation, direct evidence for its involvement is largely lacking. For example, in the butterfly Pieris brassicae, serotonin levels are higher at the beginning of diapause as compared to non-diapausing individuals 35 , and in the moth Antheraea pernyi injection of dsRNAi against the serotonin receptor 5-HTRB inhibits diapause 46 . Given that in Drosophila the serotonin receptor inhibits dILP production under normal (non-dormancy) conditions 48, 49 , and since dILPs can act as dormancy antagonists in flies 14, 15 , an attractive hypothesis is that serotonin might promote dormancy by suppressing dILPs and thus by reducing IIS (Fig. 5) .
To test this model we silenced the serotonin receptor (5-HT1A) under dormancy-inducing conditions specifically in the IPCs. In support of the idea that serotonin is required for dormancy by downregulating IIS, RNAi against 5-HT1A in the IPCs substantially decreased dormancy and led to elevated expression of dilp2 and dilp5 but reduced expression of 4E-BP, suggesting increased IIS activity. Abolishing serotonergic signaling in the IPCs is therefore sufficient to dramatically reduce dormancy levels, presumably due to the lack of inhibition of dILP Our findings are consistent with the idea that serotonin promotes dormancy by decreasing dILP release, yet paradoxically, dormant wild type flies tend to exhibit increased dilp mRNA levels 14, 15 . However, increased dilp levels might be due to compensatory upregulation of dilp expression in response to strongly reduced IIS as increased dilp expression levels often correlate with strongly decreased systemic IIS and with reduced release of dILPs from the IPCs 90, 91 .
Our results thus provide causal evidence that serotonin signaling promotes adult reproductive dormancy in Drosophila (Fig. 5 ). Together with previous results from butterflies and moths, these findings suggest that serotonin might be a conserved dormancy/diapause agonist among insects.
In several insects, dopamine seems to play a key role in diapause entry and maintenance, with diapause-destined individuals exhibiting markedly elevated dopamine levels [33] [34] [35] [36] . However, causal evidence for a Our experiments provide five lines of evidence showing that dopamine acts as a major dormancy agonist in Drosophila. First, as in several diapausing insects, dormant fruit fly females have increased dopamine levels. Second, some ple and Ddc mutants exhibit reduced dopamine levels 74, 92, 93 ; in line with this, we observed that a loss-of-function allele of ple and a Ddc hypomorph have strongly reduced levels of dormancy (Ddc is essential for both serotonin and dopamine synthesis; the failure of Ddc hyp to undergo dormancy is thus consistent with a role of both neurotransmitters in dormancy) Third, e 1 mutants with elevated dopamine 77 show increased propensity to undergo dormancy. Fourth, constitutive activation of dopaminergic neurons strongly enhanced dormancy induction. Fifth, silencing of the dopamine receptor DopR1 in the IPCs, the CA gland and in fat body, i.e. tissues critically important for dormancy physiology 1, 17, 83 , strongly decreased dormancy. Our results thus demonstrate that dopamine is a causally important promoter of dormancy.
In further support of a major role of dopamine signaling in dormancy, our assays showed that PKA signaling, downstream of DopR1 signaling, impacts dormancy entry: impairing the activity of PKA in the IPCs, CA and fat body substantially decreased the proportion of females able to enter dormancy. Impaired PKA activity specifically in the CA, the gland producing JH, led to decreased expression of 4E-BP throughout the body, thus indicating increased IIS. Similarly, consistent with increased JH signaling, we observed that the levels of Jon25Bii, known to be induced by JH, are increased and that those of obp99b, typically downregulated by JH 25 , are decreased. Interestingly, our finding that reduced PKA activity in the CA decreases 4E-BP in peripheral tissues might be consistent with observations suggesting that FOXO/IIS and JH are involved in a positive feedback loop, mutually regulating each other 89 . Our results thus lend support to a model whereby dopamine signaling promotes dormancy entry by modulating both IIS and JH signaling (Fig. 5 ). Since dopamine modulates diapause in animals as diverse as C. elegans and mammals 2,94 , dopamine signaling might represent an evolutionarily conserved (or co-opted) mechanism of dormancy/diapause regulation.
Since the expression and/or release of dILPs can be modulated by octopamine signaling (i.e., by OAMB 49,51 ) we were also interested in determining whether octopaminergic signaling affects dormancy propensity. Contrary to expectation, however, RNAi directed against OAMB in the IPCs had no effect on dormancy, perhaps suggesting that octopamine does not regulate dormancy via modulating dILP levels. Yet, in marked contrast, constitutive activation of octopaminergic neurons decreased dormancy levels. Based on these results we conjecture that, unlike serotonin and dopamine, octopamine might represent a dormancy antagonist. However, an important caveat to this interpretation is that dilp-2-3,5 mutants, which display elevated dormancy levels 15 , exhibit increased octopamine levels 95 . While the role of octopamine in dormancy physiology clearly requires further study, it is noteworthy that in C. elegans and flies, serotonin and dopamine often play opposing roles to octopamine in affecting behavior and neurophysiology, sometimes even mutually antagonizing each other [96] [97] [98] [99] [100] . We therefore hypothesize that such neurotransmitter antagonism might also be involved in the regulation of dormancy. Genetic controls and genetic background. Since SNPs at the timeless (tim) and couch potato (cpo) loci can affect dormancy 13, 101, 102 , we sought to control for potentially confounding effects of these SNPs in our experiments by determining their allelic states in all the stocks used. To genotype the tim locus we extracted genomic DNA from 5-10 females from each stock. Homogenates were incubated at 37 °C for 45 min in 50 μL of solution A (Tris HCl pH 8.2 10 mM, EDTA 2 mM, NaCl 25 mM), adding 1 μL proteinase K (10 mg/mL), followed by 3 min at 100 °C. We used amplification refractory mutation system (ARMS) PCR 13 , with the following primers: ls-tim forward: 5′-TGGAATAATCAGAACTTTGA-3′; s-tim forward: 5′-TGGAATAATCAGAACTTTAT-3′; s-tim reverse: 5′-AGATTCCACAAGATCGTGTT-3′ (common). To determine the cpo genotype of experimental strains, we collected 5 individuals from each strain employed for dormancy assays and extracted genomic DNA. The region encompassing the cpo A347V and cpo 48034(A/T) SNPs 101,102 was amplified via PCR. Templates were sequenced after purification in minicolumns (Wizard ® SV Gel and PCR Clean-Up System). We used the following primers: forward 5′-AACATCCGTTGCTGCTGTC-3′; reverse 5′-CCCCAAGCTGTCACTTTTGT-3′.
Methods
Although the "high-dormancy" allele cpo 347V102,103 was found to be present in homozygous state in the ple 4 /+ strain, this mutant exhibits a very low level of dormancy, so that the cpo SNP is unlikely to have a confounding effect on our results for ple 4 (see Supplementary Table S1 ). All other experimental genotypes (e.g. F1 of GAL4 × UAS crosses), made from crosses with a heterozygous cpo 347A/V (UAS or GAL4) parent, had segregating cpo 347V alleles, but there is no evidence that the heterozygous combination of these cpo alleles affects dormancy (see Supplementary Table S1 ). In contrast, the potentially confounding ls-tim/s-tim polymorphism SCIEnTIFIC REPORTS | (2018) 8:2030 | DOI:10.1038/s41598-018-20407-z was highly prevalent in our stocks; we thus always compared experimental and control genotypes with matching tim alleles; thus, our experimental comparisons are not confounded by the tim polymorphism (see Supplementary Table S1 ).
For GAL4 > UAS experiments we used the corresponding GAL4 and UAS lines crossed to w 1118 as controls. For experiments using mutants, we generally used w 1118 as a generic "wild type" control since the majority of the mutant strains used has been made in that background; depending on the tim genotype of the experimental F1 genotypes, we either used w 1118 (s-tim) or w 1118 (ls-tim) for control crosses (see above). Note that mutant phenotypes also differed significantly in their dormancy levels from other "control" genotypes, e.g. controls used in GAL4 > UAS assays and carried in parallel to the mutant assays (data not shown).
Many of our experiments were carried out in parallel and thus used the same internal genetic controls; for the sake of clarity we often display distinct results that involve the same controls (i.e., identical values for the controls) in separate figures. The following list states which identical controls are shown (replotted) in different contexts: dilp2-GAL4/+ (ls) (Figs 1A,G,I and 3A) ; dilp2(p)-GAL4/+ (ls) (Supplementary Figure S1A-C and Supplementary Figure S2A) ; UAS-5HT1A-RNAi/+ ( Fig. 1A and Supplementary Figure S1A) ; UAS-NaChBac/+ (Fig. 1B,H,J) ; UAS-OAMB-RNAi/+ ( Fig. 1G and Supplementary Figure S1B) ; UAS-GBR-RNAi/+ ( Fig. 1I and Supplementary Figure S1C) ; UAS-Upd2/+ ( Fig. 1K and Supplementary Figure S1D) ; UAS-DopR1-RNAi/+ (set 1: Fig. 3A and Supplementary Figure S2A) ; UAS-DopR1-RNAi/+ (set 2: Fig. 3B ,C and Supplementary Figure S2B ,C); UAS-D2R-RNAi/+ (Fig. 3B,C) and Supplementary Figure S2B,C) ; UAS-PKA-R33/+ (set 1: Fig. 3D and Supplementary Figure S2D) ; UAS-PKA-R33/+ (set 2: Fig. 3E-F) and Supplementary Figure S2E-F) ; UAS-PKA-R35/+ (Fig. 3E-F) and Supplementary Figure S2E-F) .
We note that most of the experimental controls, independent of their precise identity, showed qualitatively very similar values of dormancy incidence.
Ovarian dormancy assays. To identify positive regulators of ovarian dormancy, we used RNAi constructs (or mutants) under dormancy-inducing conditions (low temperature, short photoperiod), seeking cases of significantly decreased dormancy silencing positive regulators is expected to reduce or block dormancy under dormancy-permissive conditions. In a few cases, i.e. for manipulations expected to increase dormancy, we performed assays under long-day conditions (16 h:8 h L:D): long days can inhibit dormancy (cf. 104 ; but also see 105, 106 ; reference 106 in particular shows that dormancy in D. melanogaster is predominantly elicited by temperature), thus providing a conservative estimate of dormancy propensity. This was done for all assays involving the activation of aminergic neurons with UAS-NaChBac and the e 1 mutant (and corresponding controls).
Prior to dormancy assays, larvae were reared under standard conditions at 23 °C and 12 h:12 h L:D until eclosion. Newly eclosed virgin flies were collected (~60 females and 60 males per replicate) within 5 hours of eclosion and subsequently exposed to low temperature (12 °C) and short photoperiod (8 h:16 h L:D) for 11 days. Female ovarian dormancy was scored as the complete absence of vitellogenic oocytes (i.e., all oocytes at stages ≤ 7) by examining all ovarioles in both ovaries of each fly 11, 13, 101 . Between 4-7 replicates (~60 females each, ~300 flies in total) were assayed per genotype. In the figures, dormancy levels are shown as the percentage of dormant females ± binomial standard error (SE, in %). Percentage dormancy data were arcsine square-root transformed and analyzed with ANOVA (followed by Tukey post-hoc tests) in R (v.2.15.1); figures in the Results section show untransformed data.
qRT-PCR assays. mRNA was isolated from whole bodies (for 4E-BP we used thoraces and abdomens), generating 4 replicates per genotype, each consisting of 10-14 females; for dilps we extracted mRNA from 25 heads per replicate, with 3 replicates per genotype. mRNA was reverse-transcribed with SuperScript II First-Strand Synthesis SuperMix (Invitrogen). PCRs were performed on a 7500 Real Time PCR System (Applied Biosystems), with GoTaq qPCR Master Mix (Promega) and the following primers: dilp2 F: 5′-ATCCCGTGATTCCACACAAG-3′, R: 5′-GCGGTTCCGATATCGAGTTA-3′; dilp3 F: 5′-CCGAAACTCTCTCCAAGCTC-3′, R: 5′-GCCATCGATCTGATTGAAGTT-3′; dilp5 F: 5′-GCCTTG ATGGACATGCTGA-3′, R: 5′-CATAATCGAATAGGCCCAAGG-3′; 4E-BP F: 5′-TACACGTCCAGCGG AAAGTT-3′, R: 5′-CCTCCAGGAGTGGTGGAGTA-3′; obp99b F: 5′-AGCACGGATTCGATGTCCACAAGA-3′, R: 5′-TTGGAGTTCATGAAGCACATGCCG-3′; Jon25Bii F: 5′-CAGGCTCAGTACACCCACAC-3′, R: 5′-TGGTGTTGTAGTCCGAGTGC-3′; rp49 F: 5′-ATCGGTTACGGATCGAACAA-3′, R: 5′-GACAATCTC CTTGCGCTTCT-3′. mRNA levels were normalized to the levels of the control gene rp49 by using the 2 −ΔΔCT method. Data were analyzed with ANOVA (followed by Tukey post-hoc tests) in R (v.2.15.1).
Dopamine quantification.
To quantify dopamine levels we used dilp2-GAL4/+ as a "wildtype", with flies being exposed for 11 days to either dormancy (either 12 °C and 8 h:16 h L:D or 12 °C and 12 h:12 h L:D) or control (non-dormancy) conditions (23 °C and 12 h:12 h L:D). Three replicates of 500 females each were homogenized in ice-cold 0.1 M HClO 4 , samples centrifuged at 13.000 rcf for 10 min supernatants filtered with Minisart ® 0,45 µm filters. For dopamine quantification we used a Chromosystems catecholamine determination kit. Prior to chromatographic analysis samples were prepared as follows: 100 µL of internal standard and 6 mL of neutralization buffer were added to 3 mL of sample to adjust pH. Next, samples were purified with sample clean up columns, washed first with water and then with elution buffer. Subsequently, dopamine levels were measured with HPLC-ECD. 20 µL of eluted sample were injected in a C18 reverse-phase column (Chromsystems). Data were acquired with Geminyx software (Chromsystems) and analyzed with t-tests.
